Related references
Note: Only part of the references are listed.The Future of Cancer Treatment: Will It Include Immunotherapy?
Jeffrey A. Bluestone et al.
CANCER CELL (2012)
Inhibitory Roles of Signal Transducer and Activator of Transcription 3 in Antitumor Immunity during Carcinogen-Induced Lung Tumorigenesis
Shoichi Ihara et al.
CANCER RESEARCH (2012)
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Hanna L. M. Koskela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
Brendan D. Looyenga et al.
PLOS ONE (2012)
Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
Alfonso Quintas-Cardama et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells
A Saudemont et al.
BLOOD (2005)
Share Paper
